S Strano
Overview
Explore the profile of S Strano including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
59
Citations
1392
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Cioce M, Ganci F, Canu V, Sacconi A, Mori F, Canino C, et al.
Oncogene
. 2013 Nov;
33(46):5319-31.
PMID: 24240684
We identified a discrete number of microRNAs differentially expressed in benign or malignant mesothelial tissues. We focused on mir-145 whose levels were significantly downregulated in malignant mesothelial tissues and malignant...
2.
Ganci F, Sacconi A, Bossel Ben-Moshe N, Manciocco V, Sperduti I, Strigari L, et al.
Ann Oncol
. 2013 Oct;
24(12):3082-8.
PMID: 24107801
Background: TP53 mutation is associated with decreased survival rate in head and neck squamous cell carcinoma (HNSCC) patients. We set out to identify microRNAs (miRNAs) whose expression associates with TP53...
3.
Fausti F, Di Agostino S, Cioce M, Bielli P, Sette C, Pandolfi P, et al.
Cell Death Differ
. 2013 Aug;
20(11):1498-509.
PMID: 23933816
Werner syndrome (WS) results from dysfunction of the WRN protein, and is associated with premature aging and early death. Here we report that loss of WRN function elicits accumulation of...
4.
Masciarelli S, Fontemaggi G, Di Agostino S, Donzelli S, Carcarino E, Strano S, et al.
Oncogene
. 2013 Apr;
33(12):1601-8.
PMID: 23584479
Mutant p53 proteins are expressed at high frequency in human tumors and are associated with poor clinical prognosis and resistance to chemotherapeutic treatments. Here we show that mutant p53 proteins...
5.
Sacconi A, Biagioni F, Canu V, Mori F, Di Benedetto A, Lorenzon L, et al.
Cell Death Dis
. 2012 Nov;
3:e423.
PMID: 23152059
Micro RNAs (miRs) are small non-coding RNAs aberrantly expressed in human tumors. Here, we aim to identify miRs whose deregulated expression leads to the activation of oncogenic pathways in human...
6.
Fanciulli A, Strano S, Colosimo C, Caltagirone C, Spalletta G, Pontieri F
Eur J Neurol
. 2012 Jul;
20(2):231-5.
PMID: 22834919
Cardiovascular autonomic failure is the second most common dysautonomic feature of α-synucleinopathies and has significant impact on daily activities and quality of life. Here we provide a systematic review of...
7.
Donzelli S, Fontemaggi G, Fazi F, Di Agostino S, Padula F, Biagioni F, et al.
Cell Death Differ
. 2011 Dec;
19(6):1038-48.
PMID: 22193543
p53 mutations have profound effects on non-small-cell lung cancer (NSCLC) resistance to chemotherapeutic treatments. Mutant p53 proteins are usually expressed at high levels in tumors, where they exert oncogenic functions....
8.
Canino C, Mori F, Cambria A, Diamantini A, Germoni S, Alessandrini G, et al.
Oncogene
. 2011 Oct;
31(26):3148-63.
PMID: 22020330
Here we show that pemetrexed-treated mesothelioma cells undergo accelerated senescence. This is characterized by the secretion of proinflammatory and mitogenic cytokines, reminiscent of an SASP (senescence-associated secretory phenotype). Conditioned media...
9.
Santoro R, Marani M, Blandino G, Muti P, Strano S
Oncogene
. 2011 Oct;
31(24):2931-42.
PMID: 22002314
Several epidemiological studies have shown that high levels of melatonin, an indolic hormone secreted mainly by the pineal gland, reduce the risks of developing cancer, thus suggesting that melatonin triggers...
10.
Bianchi A, Baldini E, Suppa M, Rosa A, Coppola A, Cavicchi F, et al.
Clin Ter
. 2011 Jul;
162(3):e73-7.
PMID: 21717037
Introduction: The syncope is a common cause of admission to Emergency Departments, representing around 1-3% of all admissions to the service. However, elderly age and important comorbidities often hinder a...